1. Rogers AW, Weinstock MA, Feldman SR et al. Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the U.S. population, 2012. JAMA Dermatol 2015; 151: 1081-1086.
2.
Donaldson MR, Coldiron BM. No end in sight: the skin cancer epidemic continues. Semin Cutan Med Surg 2011; 30: 3-5.
3.
Martinez JC, Otley CC. The management of melanoma and nonmelanoma skin cancer: a review for the primary care physician. Mayo Clin Proc 2001; 76: 1253-1265.
4.
Sun Protection. Cancer Trends Progress Report-2009/2010 Update. National Cancer Institute.
5.
Richmond-Sinclair NM, Pandeya N, Ware RS et al. Incidence of basal cell carcinoma multiplicity and detailed anatomic distribution: longitudinal study of an Australian population. J Invest Dermatol 2009; 129: 323-328.
6.
Nguyen TH, Quynh-Dao Ho D. Non-melanoma skin cancer. Curr Treat Options Oncol 2002; 3: 193-203.
7.
Mosterd K, Krekels GAM, Nieman FHM et al. Surgical excision versus Mohs’ micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomized controlled trials with 5 years follow-up. Lancel Oncol 2008; 9: 1149-1156.
8.
Tormo A, Celada F, Rodriguez S et al. Nonmelanoma skin cancer treated with HDR Valencia applicator: clinical outcomes. J Contemp Brachytherapy 2014; 6: 167-172.
9.
Gauden R, Pracy M, Avery A et al. HDR brachytherapy for superficial non-melanoma skin cancer. J Med Imaging Radiat Oncol 2013; 57: 212-217.
10.
Köhler-Brock A, Pragner W, Pohlmann S et al. The indications for and results of HDR afterloading therapy in disease of the skin and mucosa with standardized surface applicators (the Leipzig applicator). Strahlenther Onkol 1999; 175: 170-174.
11.
Guix B, Finestres F, Tello JI et al. Treatment of skin carcinomas of the face by high-dose-rate brachytherapy and custom-made surface molds. Int J Radiation Oncol Biol Phys 2000; 47: 95-102.
12.
Green WH, Shakar T. History of radiation therapy in dermatology. In: Cognetta AB, Mendenhall WA (Eds.). Radiation Therapy in Skin Cancer. 1st ed. Springer, New York 2013; 1-7.
13.
Ashby MA, Smith J, Ainslie J et al. Treatment of nonmelanoma skin cancer at a large Australian center. Cancer 1989; 63: 1863-1871.
14.
Cognetta AB, Howard BM, Heaton HP et al. Superficial X-ray treatment of basal and squamous cell carcinomas: a viable option in select patients. J Am Acad Derm 2012; 67: 1235-1241.
15.
Chan S, Dhadda AS, Swindell R. Single fraction radiotherapy for small superficial carcinoma of the skin. Clin Oncol 2007; 19: 256-259.
16.
Barysch MJ, Eggmann N, Beyeler M et al. Long-term recurrence rate of large and difficult to treat cutaneous squamous cell carcinomas after superficial radiotherapy. Dermatology 2012; 224: 59-65.
17.
Van Loo E, Mosterd K, Krekels GAM et al. Surgical excision versus Mohs’ micrographic surgery for basal cell carcinoma of the face: a randomized clinical trial with 10 year follow up. Eur J Cancer 2014; 50: 3011-3020.
18.
Ballester-Sánchez R, Pons-Llanas O, Candela-Juan C et al. Electronic brachytherapy for superficial and nodular basal cell carcinoma: a report of two prospective pilot trials using different doses. J Contemp Brachytherapy 2016; 8: 1-8.
19.
Pomerantz AA, Thomas D, Lieberman R et al. Electronic HDR X-ray brachytherapy for basal and squamous cell skin cancer: Initial report of outcomes from a multicenter study. Int J Radiat Oncol Biol Phys 2015; 93: S29.
20.
Bhatnagar A. Nonmelanoma skin cancer treated with electronic brachytherapy: results at 1 year. Brachytherapy 2013; 12: 134-140.
21.
Doggett S, Willoughby M, Willoughby C et al. Incorporation of electronic brachytherapy for skin cancer into a community dermatology practice. J Clin Aesthetic Derm 2015; 8: 28-31.
22.
Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM. Ann Surg Oncol 2010; 17: 1471-1474.
23.
Pons-Llanas O, Ballester-Sánchez R, Celada-Alvarez FJ et al. Clinical implementation of a new electronic brachytherapy system for skin brachytherapy. J Contemp Brachytherapy 2014; 6: 417-423.
24.
Wolf DJ, Zitelli JA. Surgical margins for basal cell carcinoma. Arch Dermatol 1987; 23: 34-34.
25.
Welch MJ, Troiani BM, Hale L et al. Basal cell carcinoma characteristics as predictors of depth of invasion. J Am Acad Dermatol 2012; 67: 47-53.
26.
Stratigos A, Garbe C, Lebbe C et al. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline. Eur J Cancer 2015; 14: 1989-2007.
27.
Nestor M, Berman B, Goldberg D et al. Consensus guidelines on the use of superficial radiation therapy for treating nonmelanoma skin cancers and keloids. J Clin Aesthet Dermatol 2019; 12: 12-18.
28.
Cognetta AB, Jr, Wolfe CM, Goldberg DJ et al. Practice and educational gaps in radiation therapy in dermatology. Dermatol Clin 2016; 34: 319-333.
29.
Guinot JL, Rembielak A, Perez-Calatayud J et al. GEC ESTRO. GEC-ESTRO ACROP recommendations in skin brachytherapy. Radiother Oncol 2018; 126: 377-385.
30.
Shah C, Ouhib Z, Kamrava M et al. The American Brachytherapy society consensus statement for skin brachytherapy. Brachytherapy 2020; 19: 415-426.
31.
https://user-swndwmf.cld.bz/29-Skin-Cancer